However, limited alteration in TIMP gene amplifications, deep deletion or missense mutations changed platinum responses in ovarian cancer patients, with the majority becoming chemosensitive with alterations in TIMP-2, or -3 gene mutations. The gene discussed is TIMP1; the disease is ovarian carcinoma.